Age-dependency of cardiac and neuromuscular findings in left ventricular noncompaction

Claudia Stöllberger1, Maria Winkler-Dworak, Gerhard Blazek

  • 12nd Medical Department, Krankenanstalt Rudolfstiftung, Juchgasse 25, A-1030 Wien, Austria. claudia.stoellberger@chello.at

Insights

Left ventricular hypertrabeculation/noncompaction (LVHT) is a cardiac issue that can affect any age group. This study found no specific age-related patterns in clinical or echocardiographic findings associated with LVHT.

Area of Science:

  • Cardiology
  • Neurology

Background:

  • Left ventricular hypertrabeculation/noncompaction (LVHT) is a cardiac abnormality.
  • LVHT is often associated with neuromuscular disorders (NMD).
  • LVHT has been observed in both young and elderly individuals.

Purpose of the Study:

  • To assess age-dependency of clinical, electrocardiographic (ECG), and echocardiographic findings in LVHT.
  • To determine if LVHT findings differ based on neurologic diagnosis.

Main Methods:

  • Echocardiographic diagnosis of LVHT in 86 patients (median age 52 years).
  • Baseline cardiologic investigation for all patients.
  • Neurologic investigation for a subset of patients.

Main Results:

  • Older patients (>median age) showed higher rates of heart failure and valvular abnormalities.
  • Elderly patients (>71 years) presented with more exertional dyspnea, left bundle branch block, larger left-ventricular end-diastolic diameters, and lower fractional shortening.
  • No age-dependency was found for LVHT location, extension, or association with specific neurologic diagnoses.

Conclusions:

  • There is no age-dependent pattern for clinical, echocardiographic, or neurologic findings in LVHT.
  • Echocardiographers should consider LVHT in patients of all ages.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...